Myasthenia gravis and chronic inflammatory demyelinating polyneuropathy

European Journal of Neurology

Volumn 3, Issue 4, 1996, Pages 397-398

  Sempere, A P ^a,c   Claveria, L E ^a   Cruz Martinez, A ^b   Duarte, J ^a  

^a HOSPITAL GENERAL DE SEGOVIA   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c NONE   (Spain)

Author keywords

Myasthenia chronic inflammatory demyelinating polyneuropathy

Indexed keywords

AZATHIOPRINE; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; DEMYELINATING DISEASE; DISEASE ASSOCIATION; DRUG EFFICACY; ELECTROPHYSIOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MYASTHENIA GRAVIS; OPHTHALMOPLEGIA; PLASMAPHERESIS; POLYNEUROPATHY; PRIORITY JOURNAL; REMISSION;

EID: 0029762125     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1331.1996.tb00237.x     Document Type: Article

References (7)

1. Boudouresques G, Delpuech F, Giudicelli R, Poncet M, Kleisbauer JP, Daniel F, Tafani B and Khalil R (1981) Polyradiculonevrite au cours d'une myasthenie avec thymome benin. Nouveau Presse Medicale, 10, 253-254.
2. Carlander B, Touchon J, Georgesco M and Cadilhac J (1991) Myasthenia gravis and recurrent Guillain-Barré syndrome. Neurology, 41, 1848.
3. Rechthand E, Cornblath DR, Stern BJ and Meyerhoff JO (1984) Chronic demyelinating polyneuropathy in systemic lupus erythematosus. Neurology, 34, 1375-1377.
4. Regev I, Bornstein N, Carasso R and Vardi Y (1982) Acute polyneuropathy combined with myasthenia gravis. Acta Neurologica Scandinavica, 65, 681-682.
5. Ropper AH, Wijdicks EFM and Truax BT (1991) Guillain-Barré Syndrome, Contemporary Neurology Series, Chap. 10, p. 134. Philadelphia, Davis.
6. Thorlacius S, Aarli JA, Riise T, Matre R and Johnsen HJ (1989) Associated disorders in myasthenia gravis: autoimmune diseases and their relation to thymectomy. Acta Neurologica Scandinavica, 80, 290-295.
7. Yamamoto T, Vincent A, Ciulla TA, Lang B, Johnston I and Newsom-Davies J (1991) Seronegative myasthenia gravis: a plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM. Annals of Neurology, 30, 550-557.